loader
Please Wait
Applying Filters...

Ofichem Header Ofichem Header

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Approved Drug Products of Beijing Sl Pharmaceutical listed in the FDA Orange Book. Original Data : FDA Website

    Client Virtual Booth
    Menu

    BEIJING SL PHARMACEUTICAL

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Forms

    PharmaCompass

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Send me more info on How To Grow My Business Digitally?

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 FEBUXOSTAT (2)

    filter

    01 TABLET;ORAL (2)

    filter

    01 40MG (1)

    02 80MG (1)

    filter

    01 Blank (2)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us
    Contact Supplier
      Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
      Post an Enquiry Post an Enquiry
      Flag China
      Virtual Booth Virtual Booth
      Digital Content Digital Content

      FEBUXOSTAT

      PDF Supplier PDF
      URL Supplier Web Content
      TABLET; ORAL
      40MG
      211339
      FEBUXOSTAT
      ASK
      US
      PHARMACOMPASS
      Upload
      your Marketing & Sales content
      Contact Supplier
        Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
        Post an Enquiry Post an Enquiry
        Flag China
        Virtual Booth Virtual Booth
        Digital Content Digital Content

        FEBUXOSTAT

        PDF Supplier PDF
        URL Supplier Web Content
        TABLET; ORAL
        80MG
        211339
        FEBUXOSTAT
        ASK
        US
        PHARMACOMPASS
        Upload
        your Marketing & Sales content
        Post Enquiry
        POST ENQUIRY